Prnewswire·2026-03-06 22:00Group 1 - Equifax Inc. has been named "Stock to Study" by BetterInvesting Magazine for May 2026, indicating potential interest from investors regarding its stock valuation [1] - The report highlights key financial metrics for Equifax, including sales, earnings, pre-tax profit, and return on equity, which can be accessed through the National Association of Investors Corp [2] - BetterInvesting Magazine will also feature a fundamental review of Neurocrine Bio Inc. (NASDAQ: NBIX), suggesting it is considered undervalued and worthy of further study [3] Group 2 - The Editorial Advisory and Securities Review Committee of BetterInvesting consists of several CFA members, indicating a professional and knowledgeable review process [3] - BetterInvesting is a nonprofit organization focused on investment education, having empowered over 5 million individuals since its inception in 1951 [5] - The organization provides tools and resources for investors to improve their financial literacy and investment strategies [5]